Tag: am-trastuzumab deruxtecan-nxki

Home / am-trastuzumab deruxtecan-nxki

Categories

Accelerated approval is granted by FDA to fam-trastuzumab deruxtecan-nxki for HER2-mutant non-small cell lung cancer

August 2022: For adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have a mutation resulting in mesenchymal-epithelial transition (MET) exon 14 skipping, as detected by ...
am-trastuzumab-deruxtecan-nxki

Scan the code